{"version":"1.0","provider_name":"FYB Financial Yearbook","provider_url":"https:\/\/www.fyb.de\/en\/","author_name":"Tatjana Anderer","author_url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/","title":"UCB sells UCB Internal Medicine to Paragon Partners - FYB Financial Yearbook","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Jf0amHbaG8\"><a href=\"https:\/\/www.fyb.de\/en\/ucb-sells-ucb-internal-medicine-to-paragon-partners\/\">UCB sells UCB Internal Medicine to Paragon Partners<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.fyb.de\/en\/ucb-sells-ucb-internal-medicine-to-paragon-partners\/embed\/#?secret=Jf0amHbaG8\" width=\"600\" height=\"338\" title=\"&#8220;UCB sells UCB Internal Medicine to Paragon Partners&#8221; &#8212; FYB Financial Yearbook\" data-secret=\"Jf0amHbaG8\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/07\/a-dc-advisory-logo.png","thumbnail_width":251,"thumbnail_height":289,"description":"Mohnheim\/ Frank\u00adfurt a. M. \u2014 UCB S.A. has sold its subsi\u00addiary UCB Innere Medi\u00adzin to Para\u00adgon Part\u00adners. DC Advi\u00adsory advi\u00adsed UCB S.A. on the transaction. UCB Inn ere Medi\u00adzin (\u201cInter\u00adnal Medi\u00adcine\u201d), which has been opera\u00adting as an inde\u00adpen\u00addent busi\u00adness unit of UCB since March 2016, has been successfully marke\u00adting drugs in the field of cardio\u00advas\u00adcu\u00adlar [&hellip;]"}